PRE 14A

REXAHN PHARMACEUTICALS INC PRE 14A 6-4-2015

Company: Opus Genetics, Inc.
Filed: March 30, 2015
Period of Report: June 4, 2015
Accession Number: 0001140361-15-013488

View Document ↗ View on SEC.gov ↗